Alternatively, it could be hypothesized that an excess of vWF in the blood may act as a trigger for TTP and increase the incidence of the disease, which would explain the decreasing trend of TTP in individuals with blood group O as reported in the literature; further studies are needed. The gene discussed is VWF; the disease is thrombotic thrombocytopenic purpura.